Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report

  • Marcella Tazzari1, 7,
  • Elena Palassini2, 7,
  • Barbara Vergani3,
  • Antonello Villa3,
  • Francesca Rini1, 7,
  • Tiziana Negri4, 7,
  • Chiara Colombo5, 7,
  • Flavio Crippa6, 7,
  • Carlo Morosi6, 7,
  • Paolo G Casali2, 7,
  • Silvana Pilotti4, 7,
  • Silvia Stacchiotti2, 7Email author,
  • Licia Rivoltini1, 7 and
  • Chiara Castelli1, 7
BMC Cancer201515:58

https://doi.org/10.1186/s12885-015-1044-0

Received: 17 July 2014

Accepted: 27 January 2015

Published: 14 February 2015

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
17 Jul 2014 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
27 Jan 2015 Editorially accepted
14 Feb 2015 Article published 10.1186/s12885-015-1044-0

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Experimental Oncology and Molecular Medicine, Unit of Immunotherapy of Human Tumours
(2)
Department of Cancer Medicine, Adult Sarcoma Medical Oncology Unit
(3)
Consorzio MIA (Microscopy and Image Analysis), University of Milano-Bicocca
(4)
Department of Diagnostic Pathology and Laboratory, Laboratory of Experimental Molecular Pathology
(5)
Department of Surgery
(6)
Radiology
(7)
Fondazione IRCCS Istituto Nazionale dei Tumori

Advertisement